Silencing of ENO1 gene in a breast cancer cell line reduced the proliferative capacity of the cells (Zhang et al., 2020), indicating that ENO1 could be a potential molecular prognostic marker or therapeutic target in breast cancer. The gene discussed is ENO1; the disease is breast cancer.